Natus Medical Awarded Key New Government Contract

Natus Medical Awarded Key New Government Contract

Written by Customer Service on . Posted in Public Companies.

Paves the Way for Purchase of Natus Medical Equipment Through United States Government Healthcare System Electronic Catalog

PLEASANTON, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is pleased to announce the award of a 5-year contract to include Natus Patient Monitoring and Capital Equipment (PMCE) in the electronic catalog (ECAT). The PMCE contract is pre-established and pre-vetted by the Defense Logistics Agency (DLA) as a source for medical equipment and acts as a preferred purchasing source for United States government healthcare systems. ECAT, as an on-line ordering, distribution and payment solution facilitates over $1B in purchase activity annually.

The PMCE contract and ECAT integration will now provide easier access for the Department of Defense (DoD) and Veterans Affairs (VA) health systems to purchase many products across the Natus portfolio, including neurodiagnostic, audiology and newborn care equipment and supplies. The initial 5-year contract term also includes an additional 5-year extension option.

“We are excited to achieve this important milestone,” says Jonathan Kennedy, Natus CEO. “This agreement and Natus inclusion in the electronic catalog solution will dramatically improve the transaction process, making it easier for us to partner with government healthcare systems and provide our innovative solutions to the United States veteran and active-duty military patients in need.”  

About Natus Medical Incorporated

Natus Medical Incorporated improves patient outcomes using the most comprehensive product solutions, depth of training and continuing customer care when diagnosing and treating central nervous and sensory system disorders for patients of all ages.

Additional information about Natus Medical Incorporated can be found at https://natus.com.

Contacts:
Natus Medical Incorporated
Drew Davies
Executive Vice President and Chief Financial Officer
(925) 223-6700
InvestorRelations@Natus.com                

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.